Original Research

Published on 05 Oct 2023

Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure

in Cancer Immunity and Immunotherapy

Xingyuan Li
Huayan Huang
Yingjia Sun
Qing Jiang
Yongfeng Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1265236

2,479 views
1 citation

Case Report

Published on 05 Oct 2023

Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancer

in Cancer Immunity and Immunotherapy

Hirofumi Ohmura
Moe Kondo
Masato Uenomachi
Hiroshi Ariyama
Mamoru Ito
Kenji Tsuchihashi
Masahiro Ayano
Hiroaki Niiro
Koichi Akashi
Eishi Baba

Frontiers in Oncology

doi 10.3389/fonc.2023.1260818

2,620 views
1 citation

Case Report

Published on 05 Oct 2023

PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review

in Cancer Immunity and Immunotherapy

Sheng Liu
Rui Xiong
Chuanyi Duan
Jiang Tang
Tao Yin
Sisi Dai

Frontiers in Oncology

doi 10.3389/fonc.2023.1199143

1,617 views
1 citation

Original Research

Published on 05 Oct 2023

Integrative analysis of triphenyl phosphate: contextual interpretation of bladder cancer cohort

in Cancer Immunity and Immunotherapy

Xiaolei Zhang
Wen Huang
Tao Huang
Jiayi Zhang
Aiming Xu
Yidong Cheng
Chao Qin
Qiang Lu
Zengjun Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1260114

1,771 views

Original Research

Published on 04 Oct 2023

A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients

in Cancer Immunity and Immunotherapy

Hong Chen
Shan Wang
Yuting Zhang
Xue Gao
Yufu Guan
Nan Wu
Xinyi Wang
Tianyang Zhou
Ying Zhang
Di Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1209707

2,622 views
1 citation

Original Research

Published on 04 Oct 2023

Identification and validation of PCSK9 as a prognostic and immune-related influencing factor in tumorigenesis: a pan-cancer analysis

in Cancer Immunity and Immunotherapy

Chao Sun
Guoji Zhu
Conghuan Shen
Shungen Huang
Ruidong Li
Jianhua Li
Zhenyu Ma
Zhengxin Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1134063

3,119 views
4 citations

Original Research

Published on 02 Oct 2023

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma

in Cancer Immunity and Immunotherapy

Xinyu Zhai
Xinglin Chen
Jianyi Gu
Dongdong Guo
Xiangyang Zhan
Mingyue Tan
Dongliang Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1256720

1,481 views

Original Research

Published on 02 Oct 2023

The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling

in Cancer Immunity and Immunotherapy

Song Li
Dianze Chen
Huiqin Guo
Dandan Liu
Chunmei Yang
Ruliang Zhang
Tianxiang Wang
Fan Zhang
Xing Bai
Yanan Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1240061

3,388 views
2 citations

Case Report

Published on 02 Oct 2023

Severe thyrotoxicosis induced by tislelizumab: a case report and literature review

in Cancer Immunity and Immunotherapy

Liman Huo
Chao Wang
Haixia Ding
Xuelian Shi
Bin Shan
Ruoying Zhou
Ping Liang
Juan Hou

Frontiers in Oncology

doi 10.3389/fonc.2023.1190491

2,434 views
3 citations

Original Research

Published on 02 Oct 2023

Inflammatory cell death induced by 5-aminolevulinic acid-photodynamic therapy initiates anticancer immunity

in Cancer Immunity and Immunotherapy

Lingyan Wang
Vipin Shankar Chelakkot
Nick Newhook
Stephanie Tucker
Kensuke Hirasawa

Frontiers in Oncology

doi 10.3389/fonc.2023.1156763

2,084 views
2 citations

Systematic Review

Published on 29 Sep 2023

PD-1/PD-L1 inhibitor treatment and its impact on clinical imaging in non-small cell lung cancer: a systematic review and meta-analysis of immune-related adverse events

in Cancer Immunity and Immunotherapy

Nader Mohammed
En-Hua Xiao
Shallal Mohsen
Zeng Xiong
RongRong Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1191681

2,414 views
3 citations

Original Research

Published on 28 Sep 2023

Study of prevalence and risk factors of chemotherapy-induced mucositis in gastrointestinal cancer using machine learning models

in Cancer Immunity and Immunotherapy

Lin Huang
Xianhui Ye
Fengqing Wu
Xiuyun Wang
Meng Qiu

Frontiers in Oncology

doi 10.3389/fonc.2023.1138992

2,013 views
1 citation

Review

Published on 26 Sep 2023

Circadian rhythm disorders in patients with advanced cancer: a scoping review

in Cancer Immunity and Immunotherapy

Craig Gouldthorpe
Jenny Power
Andrew Davies

Frontiers in Oncology

doi 10.3389/fonc.2023.1240284

1,859 views

Review

Published on 22 Sep 2023

The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer

in Cancer Immunity and Immunotherapy

Yihan Sun
Genyi Jiang
Qianhua Wu
Lei Ye
Bilan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1213347

3,474 views
3 citations

Original Research

Published on 22 Sep 2023

A nomogram based on the preoperative neutrophil-to-lymphocyte ratio to distinguish sarcomatoid renal cell carcinoma from clear cell renal cell carcinoma

in Cancer Immunity and Immunotherapy

Yijian Wu
Tienan Qi
Xin Qin
Zhongwei Zhao
Jianguo Zheng
Qinglong Du
Nengwang Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1218280

1,520 views

Original Research

Published on 19 Sep 2023

The safety and efficacy of PD-1 inhibitors in patients with advanced cancers and HIV/AIDS in China

in Cancer Immunity and Immunotherapy

Yu Xiong
Pingzheng Mo
Yajun Yan
Shan Wang
Ke Zhuang
Zhiyong Ma
Xiaoping Chen
Liping Deng
Yong Xiong
Di Deng

Frontiers in Oncology

doi 10.3389/fonc.2023.1248790

1,733 views
3 citations

Navigation group

Articles

Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure

Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancer

PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review

Integrative analysis of triphenyl phosphate: contextual interpretation of bladder cancer cohort

A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients

Identification and validation of PCSK9 as a prognostic and immune-related influencing factor in tumorigenesis: a pan-cancer analysis

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma

The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling

Severe thyrotoxicosis induced by tislelizumab: a case report and literature review

Inflammatory cell death induced by 5-aminolevulinic acid-photodynamic therapy initiates anticancer immunity

PD-1/PD-L1 inhibitor treatment and its impact on clinical imaging in non-small cell lung cancer: a systematic review and meta-analysis of immune-related adverse events

Study of prevalence and risk factors of chemotherapy-induced mucositis in gastrointestinal cancer using machine learning models

Circadian rhythm disorders in patients with advanced cancer: a scoping review

The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer

A nomogram based on the preoperative neutrophil-to-lymphocyte ratio to distinguish sarcomatoid renal cell carcinoma from clear cell renal cell carcinoma

The safety and efficacy of PD-1 inhibitors in patients with advanced cancers and HIV/AIDS in China